The healthcare sector in India is undergoing a transformative journey, and Constellation Blu is proud to play a pivotal role in supporting this change. We are thrilled to announce that we served as advisors to Blume Ventures for its investment in Zoplar, a cutting-edge platform revolutionizing medical equipment procurement for small and medium-sized hospitals, in their successful $3.4 million Series A funding round.
Led by Blume Ventures, this funding round also witnessed participation from Beenext, Saison Capital, Atrium Angels, Finfirst, and LogX. With this latest investment, Zoplar’s total funding stands at $5.1 million, with previous contributions from Titan Capital, Stride Ventures, and Panthera Peak.
This funding marks a significant milestone in Zoplar’s mission to enhance India’s healthcare infrastructure. The company aims to strengthen its supply chain through backward integration, build a robust service engineering team, and set new standards in after-sales service—critical components in making quality healthcare accessible and reliable.
At Constellation Blu, we take pride in working with visionary entrepreneurs like Amit Sah and Umesh Sharma, the co-founders of Zoplar, who are dedicated to empowering healthcare providers and improving patient outcomes. Our role in this transaction reaffirms our commitment to fostering innovative solutions that drive impactful change.
We congratulate the entire Zoplar team and their investors on this remarkable achievement. Together, we are enabling a brighter and healthier future for India’s healthcare ecosystem.
Comments